Question

Analyze the Structure of the Industry- Biogen ( 2 page non plagarised please)

Answer 1

Biogen and structure of Industry

1. It is a multinational American company focus on Biotechnology
2. It is founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert and Phillip Sharp
3. The Headquarters of Biogen is in Cambridge, Massachusetts, The U.S.
4. The Main goal of Biogen is to prevent Neurological diseases such as Parkinsons, Alzheimers, Multiple Sclerosis, Amyotrophic lateral sclerosis.( ALS). It also engaged with Spinal Muscular Atrophy and Progressive Supranuclear Palsy
5. Biogen has the best Neurologists and Neuroscientists who dedicated in discovery and development of Neuroscience
6. Biogen produces high quality medicines to overcome neurological diseases. It has a great value in the market
7. It also made a platform for autoimmune,inflammatory and fibrotic diseases
8. Biogen is also Collaborated ( Corporate) with ADIMAB, AGTC, CTTV , EISAI, GALAPAGOS NV, IONIS PHARMACEUTICALS and SAMSUNG BIOEPIS
9. It has a tie up with may academics such as UNIVERSITY OF PENNSYLVANIA, MASSACHUSETTS INSTITUTE OF TECHNOLOGY AND BIOMEDICAL RESEARCH, HARVARD MEDICAL SCHOOL, RUBIN LABORATORY, ALS CONSORTIUM, DUKE UNIVERSITY, HUDSON ALPHA INSTITUTE OF BIOTECHNOLOGY, COLUMBIA UNIVERSITY, FIBROSIS CONSORTIUM, EPIGENETICS CONSORTIUM, SCLERODERMA CONSORTIUM, ACCELERATING MEDICINES PARTNERSHIP, a LAWRENCE BERKELEYNATIONAL LAB and UNIVERSITY OF CONNECTICUT HEALTH CENTER
10. The therapies of Biogen are AVONEX, FAMPYRA, PLEGRIDY,TECFIDERA, TYSABRI, ZINBRYTA, SPINRAZA, BENEPALI, FLIXABI, IMRALDI, GAZYVA and RITUXAN
11. The Board of Directors
12. Stelios Papadopoulos ( chairman), Alexander.J.Denner, (Director and Chair,corporate governance committee, Caroline.D.Dorsa (Director and Chair Audit Committee), Nancy L Leaming ( Director), Richard.C. Mulligan (Director and Chair, Science and technology committee), Robert.W.Pangia( Director and Chair, compensation and management development committee), Brian.S.Posner (Director and Chair, Finance committee), Eric.K.Rowinsky (Director), Lynn Schenk (Director and Chair, Risk Committee), Stephen.A.Sherwin (Director), Michel Vounatsos (Chief Executive Officer and Director)
13. Executive Leadership
14. Michel Vounatsos (CEO), Susan Alexander (Executive Vice President, Chief Legal, Corporate Services and Secretary), Jeffrey Capello (Executive Vice president and Chief Financial Officer), Michael Ehlers ( Executive Vice President, Research and Development), Ginger Gregory ( Executive Vice President and Human Resources Officer), Chirfi Guindo (Executive Vice President and Head Of Global Marketing, Market Access and Customer Innovation), Paul Mckenzie ( Executive Vice President Pharmaceutical operations and technology, Alfred Sandrock ( Executive Vice President and Chief Medical Officer)
15. Bogen Foundation supports Science education and Strengthening communities. It also supports non profit organizations that provides
16. Hands-on Science education
17. Teacher development opportunities in Science
18. college readiness and support
19. Basic social needs such as
20. child hunger
21. Poverty
22. Social Mobility
23. Biogen Foundation is also a part of
24. U.S. Grants Program
25. International Grants Program
26. U.S. Employee Matching Gifts Program